Robotic surgical systems are designed to solve the limitations currently present in minimally invasive surgeries (MIS), as well as to improve outcomes in open surgical procedures. These systems are utilized in a variety of surgical procedures, including cardiovascular, general surgery, orthopedic, neurosurgery, obstetrics, gynecology, and more.
Usage of robotic surgical systems varies widely by therapy area and geography. While some procedures, such as prostatectomy, exhibit heavy robotic system use, other areas such as cardiovascular and neurosurgery have not yet experienced wide adoption. Improved surgical systems for more complex procedures will enable more widespread growth in procedure usage. Additionally, the high cost of the surgical system is driving many facilities to utilize it in as many ways as possible in order to recoup the device cost.
The market for robotic surgery is expected to grow throughout the forecast period, amidst increasing competition for the market leader, Intuitive Surgical, from players such as Verb Surgical and Titan Medical. Increasing adoption of robotics systems will be fueled by a growing body of supporting data, as well as a growing number of indications. As robotic systems serve to improve surgical procedures, this will in turn increase the patient population eligible for treatment, as well as reduce complications and negative outcomes.
Who should buy this report?
- CMO executives who must have deep understanding of the Robotic Surgery marketplace to make strategic planning and investment decisions.
- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
- Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.